247 related articles for article (PubMed ID: 11823957)
21. Challenges for the clinical development of new nucleoside reverse transcriptase inhibitors for HIV infection.
Wainberg MA; Sawyer JP; Montaner JS; Murphy RL; Kuritzkes DR; Raffi F
Antivir Ther; 2005; 10(1):13-28. PubMed ID: 15751760
[TBL] [Abstract][Full Text] [Related]
22. Can HIV infection be treated successfully with a once-daily regimen?
Pollard RB
AIDS Read; 2002 Nov; 12(11):489-90, 494-8, 500, 508. PubMed ID: 12498154
[TBL] [Abstract][Full Text] [Related]
23. Successful simplification of HAART in patients with acute primary HIV infection.
Sinicco A; Bonora S; Arnaudo I; Zeme DA; Audagnotto S; Raiteri R; Di Perri G
J Biol Regul Homeost Agents; 2002; 16(1):69-72. PubMed ID: 12003178
[TBL] [Abstract][Full Text] [Related]
24. Boosted protease inhibitor-based or nonnucleoside reverse transcriptase-based HAART: is there a best choice for antiretroviral-naive HIV-1 infected patients?
Cuzin L; Allavena C; Morlat P; Dellamonica P
AIDS Rev; 2008; 10(4):205-11. PubMed ID: 19092976
[TBL] [Abstract][Full Text] [Related]
25. Change to a once-daily combination including boosted atazanavir in HIV-1-infected children.
Macassa E; Delaugerre C; Teglas JP; Jullien V; Tréluyer JM; Veber F; Rouzioux C; Blanche S
Pediatr Infect Dis J; 2006 Sep; 25(9):809-14. PubMed ID: 16940839
[TBL] [Abstract][Full Text] [Related]
26. Long-term analysis of the resistance development in HIV-1 positive patients treated with protease and reverse transcriptase inhibitors: correlation of the genotype and disease progression.
Václavíková J; Weber J; Machala L; Reinis M; Linka M; Brůcková M; Vandasová J; Stanková M; Konvalinka J
Acta Virol; 2005; 49(1):29-36. PubMed ID: 15929396
[TBL] [Abstract][Full Text] [Related]
27. The Place of protease inhibitors in antiretroviral treatment.
Tenore SB; Ferreira PR
Braz J Infect Dis; 2009 Oct; 13(5):371-4. PubMed ID: 20428639
[TBL] [Abstract][Full Text] [Related]
28. Adherence, resistance, and timing: current issues in the use of new therapies.
Volberding P
AIDS Read; 2002 Aug; 12(8):349-50, 356-7, 368. PubMed ID: 12229892
[TBL] [Abstract][Full Text] [Related]
29. Benefits and concerns of simplification strategies in HIV-infected patients.
Negredo E; Bonjoch A; Clotet B
J Antimicrob Chemother; 2006 Aug; 58(2):235-42. PubMed ID: 16807250
[TBL] [Abstract][Full Text] [Related]
30. A once-daily HAART regimen containing indinavir + ritonavir plus one or two nucleoside reverse transcriptase inhibitors (PIPO study).
Burger DM; Aarnoutse RE; Dieleman JP; Gyssens IC; Nouwen J; de Marie S; Koopmans PP; Stek M; van der Ende ME
Antivir Ther; 2003 Oct; 8(5):455-61. PubMed ID: 14640393
[TBL] [Abstract][Full Text] [Related]
31. Immunovirologic consequences and safety of short, non-structured interruptions of successful antiretroviral treatment.
Sanchez R; Portilla J; Gimeno A; Boix V; Llopis C; Sanchez-Paya J; Merino E; de la Sen ML; Muñoz C; Reus S; Plazas J
J Infect; 2007 Feb; 54(2):159-66. PubMed ID: 16690132
[TBL] [Abstract][Full Text] [Related]
32. Therapy of HIV infection.
Chang YC; Tyring SK
Dermatol Ther; 2004; 17(6):449-64. PubMed ID: 15571495
[TBL] [Abstract][Full Text] [Related]
33. Antiviral therapy: how simple can you get?
Gilden D
GMHC Treat Issues; 1998 Nov; 12(11):3-7. PubMed ID: 11365906
[TBL] [Abstract][Full Text] [Related]
34. Antiretroviral agents: the next generation.
Deeks SG
AIDS Clin Care; 1998 May; 10(5):33-6, 39-40. PubMed ID: 11365427
[TBL] [Abstract][Full Text] [Related]
35. Treating an HIV-infected paediatric patient: an easy task?
Rakhmanina NY; van den Anker JN
Antivir Ther; 2010; 15(3):293-6. PubMed ID: 20516549
[TBL] [Abstract][Full Text] [Related]
36. Attaining higher goals in HIV treatment: the central importance of adherence.
Friedland GH; Williams A
AIDS; 1999 Sep; 13 Suppl 1():S61-72. PubMed ID: 10546786
[TBL] [Abstract][Full Text] [Related]
37. Simplifying drug regimens goal of research.
Gaylord G
Posit Living; 1999 Nov; 8(10):6, 56. PubMed ID: 11367337
[TBL] [Abstract][Full Text] [Related]
38. [Progress toward a once daily regimen. (HA)ART--the art of antiretroviral therapy].
MMW Fortschr Med; 2001 Apr; 143 Suppl 1():78-9. PubMed ID: 11373790
[No Abstract] [Full Text] [Related]
39. HIV chemotherapy.
Richman DD
Nature; 2001 Apr; 410(6831):995-1001. PubMed ID: 11309630
[TBL] [Abstract][Full Text] [Related]
40. [Salvage therapy in HIV disease].
Ajisawa A
Nihon Rinsho; 2002 Apr; 60(4):745-9. PubMed ID: 11968782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
